CA1302886C - Pharmaceutical composition containing a benzodiazepin derivative - Google Patents
Pharmaceutical composition containing a benzodiazepin derivativeInfo
- Publication number
- CA1302886C CA1302886C CA000547518A CA547518A CA1302886C CA 1302886 C CA1302886 C CA 1302886C CA 000547518 A CA000547518 A CA 000547518A CA 547518 A CA547518 A CA 547518A CA 1302886 C CA1302886 C CA 1302886C
- Authority
- CA
- Canada
- Prior art keywords
- temazepam
- insomnia
- capsule
- less
- surface area
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- SVUOLADPCWQTTE-UHFFFAOYSA-N 1h-1,2-benzodiazepine Chemical class N1N=CC=CC2=CC=CC=C12 SVUOLADPCWQTTE-UHFFFAOYSA-N 0.000 title description 2
- 239000008194 pharmaceutical composition Substances 0.000 title description 2
- SEQDDYPDSLOBDC-UHFFFAOYSA-N Temazepam Chemical compound N=1C(O)C(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 SEQDDYPDSLOBDC-UHFFFAOYSA-N 0.000 claims abstract description 51
- 229960003188 temazepam Drugs 0.000 claims abstract description 50
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 claims abstract description 17
- 206010022437 insomnia Diseases 0.000 claims abstract description 17
- 239000007903 gelatin capsule Substances 0.000 claims description 22
- 239000002775 capsule Substances 0.000 claims description 17
- 239000002245 particle Substances 0.000 claims description 16
- 239000003937 drug carrier Substances 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 230000004622 sleep time Effects 0.000 description 6
- 238000000034 method Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 230000004620 sleep latency Effects 0.000 description 5
- 239000000902 placebo Substances 0.000 description 4
- 229940068196 placebo Drugs 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 239000003326 hypnotic agent Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910052743 krypton Inorganic materials 0.000 description 1
- DNNSSWSSYDEUBZ-UHFFFAOYSA-N krypton atom Chemical compound [Kr] DNNSSWSSYDEUBZ-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91057186A | 1986-09-23 | 1986-09-23 | |
| US910,571 | 1986-09-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1302886C true CA1302886C (en) | 1992-06-09 |
Family
ID=25429005
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000547518A Expired - Lifetime CA1302886C (en) | 1986-09-23 | 1987-09-22 | Pharmaceutical composition containing a benzodiazepin derivative |
Country Status (8)
| Country | Link |
|---|---|
| JP (1) | JPS63101325A (de) |
| BE (1) | BE1000318A4 (de) |
| CA (1) | CA1302886C (de) |
| CH (1) | CH673947A5 (de) |
| DE (1) | DE3731840A1 (de) |
| FR (1) | FR2604091B1 (de) |
| GB (1) | GB2195242A (de) |
| IT (1) | IT1221509B (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19603402A1 (de) * | 1995-02-24 | 1996-08-29 | Basf Ag | Weichgelatinekapseln |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL60806A0 (en) * | 1979-09-14 | 1980-10-26 | Sparamedica Ag | Pharmaceutical compositions containing a benzodiazepine derivatives and a neuroleptic |
| DE3033919A1 (de) * | 1980-09-09 | 1982-04-22 | Bayer Ag, 5090 Leverkusen | Feste arzneizubereitungen enthaltend nifedipin und verfahren zu ihrer herstellung |
| GB8305693D0 (en) * | 1983-03-02 | 1983-04-07 | Scherer Ltd R P | Pharmaceutical compositions |
| DE3307353C2 (de) * | 1983-03-02 | 1985-01-31 | R.P. Scherer GmbH, 6930 Eberbach | Polyethylenglykolhaltige Weichgelatinekapsel und Verfahren zu ihrer Herstellung |
| WO1987000428A1 (en) * | 1985-07-24 | 1987-01-29 | Pyare Seth | Oxazepam containing pharmaceutical composition |
-
1987
- 1987-09-18 CH CH3616/87A patent/CH673947A5/de not_active IP Right Cessation
- 1987-09-21 FR FR878713108A patent/FR2604091B1/fr not_active Expired
- 1987-09-21 BE BE8701058A patent/BE1000318A4/fr not_active IP Right Cessation
- 1987-09-21 GB GB08722205A patent/GB2195242A/en not_active Withdrawn
- 1987-09-22 DE DE19873731840 patent/DE3731840A1/de not_active Withdrawn
- 1987-09-22 JP JP62236428A patent/JPS63101325A/ja active Pending
- 1987-09-22 CA CA000547518A patent/CA1302886C/en not_active Expired - Lifetime
- 1987-09-22 IT IT48408/87A patent/IT1221509B/it active
Also Published As
| Publication number | Publication date |
|---|---|
| GB8722205D0 (en) | 1987-10-28 |
| IT1221509B (it) | 1990-07-06 |
| CH673947A5 (de) | 1990-04-30 |
| DE3731840A1 (de) | 1988-03-31 |
| FR2604091B1 (fr) | 1989-05-05 |
| GB2195242A (en) | 1988-04-07 |
| BE1000318A4 (fr) | 1988-10-18 |
| FR2604091A1 (fr) | 1988-03-25 |
| JPS63101325A (ja) | 1988-05-06 |
| IT8748408A0 (it) | 1987-09-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5030632A (en) | Low dose temazepam | |
| US4721709A (en) | Novel pharmaceutical compositions containing hydrophobic practically water-insoluble drugs adsorbed on pharmaceutical excipients as carrier; process for their preparation and the use of said compositions | |
| EP0124027B1 (de) | Schnellösliche homogene Heilmittelzusammensetzungen | |
| US4692337A (en) | Sustained release pharmaceutical tablet of theophylline and production process thereof | |
| US4562069A (en) | Two-phase formulation | |
| JPS59101423A (ja) | 新規なニフエジピン固形製剤 | |
| JPS5914446B2 (ja) | ニフエジピン含有固形製剤及びその製造方法 | |
| US3621096A (en) | Antidepressant method and composition for same comprising a tricyclic antidepressant and a thyroid hormone | |
| EP1707192B1 (de) | Pharmazeutische Zusammensetzung | |
| US4772627A (en) | Ground mixture | |
| GB2196852A (en) | Sustained release composition | |
| AU6508400A (en) | Beta-carboline drug products | |
| US5399360A (en) | Pharmaceutical compositions | |
| CA1335573C (en) | Dispersible tablets of dihydroergotoxine and of acid addition salts thereof | |
| CN113368071A (zh) | 一种含盐酸伐地那非三水合物的口服固体制剂及其制备方法 | |
| US5211954A (en) | Low dose temazepam | |
| KR101343405B1 (ko) | 피리딘 대사능의 측정에 유용한 경구 제제 | |
| CA1302886C (en) | Pharmaceutical composition containing a benzodiazepin derivative | |
| US5629310A (en) | Low dose temazepam | |
| EP4233862A1 (de) | Medikament zur linderung oder beseitigung von protrahiertem opioidabstinenzsyndrom und herstellungsverfahren dafür | |
| Alfieri et al. | Treatment with para-chlorophenylalanine antagonises the emetic response and the serotonin-releasing actions of cisplatin in cancer patients | |
| CN111617042A (zh) | 一种复合碳酸钙维生素d3无水吞服颗粒及其制备方法 | |
| JP2001097856A (ja) | 鎮咳剤 | |
| CN114601803B (zh) | 一种巴洛沙韦酯干混悬剂及其制备方法和应用 | |
| Nishihata | Simple formulation of sustained-release tablets of sodium diclofenac and examination in humans |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |